Can We Achieve Personalized Medicine?

Jayson Slotnik, JD, MPH

Video Categories: Value

Jayson Slotnick discusses the definition and feasibility of personalized medicine
September 2, 2015

Overview of Ixazomib

Dixie-Lee Esseltine, MD provides a brief overview of the dosing schedule and indications of ixazomib. She also reviews the phase 3 clinical trials of ixazomib that are currently ongoing.

December 3, 2013

Basal Cell Carcinoma Case Studies in Hedgehog Pathway Inhibition

In this final WCMC clinical commentary entitled, The Impact of Hedgehog Pathway Inhibitors on the Management of Patients with Basal Cell Carcinoma, Joel Claveau, MD, CSPQ, FRCPC; Dirk Schadendorf, MD; Nicole Basset-Seguin, MD, PhD and Aleksandar Sekulic, MD, PhD discuss how Hedgehog Pathway Inhibitors opened a new chapter of treatment [ Read More ]